An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo

In this study we tested the in vitro and in vivo anti-Cryptococcus neoformans activity of an antilaminarin (anti-β-glucan) monoclonal antibody (MAb 2G8) (immunoglobulin G2b) which was previously shown to inhibit the growth of β-glucan-exposing Candida albicans cells. Here we show that MAb 2G8 binds...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rachini, Anna, Pietrella, Donatella, Lupo, Patrizia, Torosantucci, Antonella, Chiani, Paola, Bromuro, Carla, Proietti, Carla, Bistoni, Francesco, Cassone, Antonio, Vecchiarelli, Anna
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2007
Soggetti:
Fungal and Parasitic Infections
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2168274/
https://ncbi.nlm.nih.gov/pubmed/17606600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00278-07
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi